Logo image of NYXH.BR

NYXOAH SA (NYXH.BR) Stock Price, Quote, News and Overview

EBR:NYXH - Euronext Brussels - BE0974358906 - Common Stock - Currency: EUR

9.24  -0.12 (-1.28%)

NYXH.BR Quote, Performance and Key Statistics

NYXOAH SA

EBR:NYXH (3/7/2025, 7:00:00 PM)

9.24

-0.12 (-1.28%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High17.6
52 Week Low6.26
Market Cap345.85M
Shares37.43M
Float23.09M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-13 2025-03-13/amc
IPO09-18 2020-09-18


NYXH.BR short term performance overview.The bars show the price performance of NYXH.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

NYXH.BR long term performance overview.The bars show the price performance of NYXH.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of NYXH.BR is 9.24 EUR. In the past month the price decreased by -10.72%. In the past year, price decreased by -34%.

NYXOAH SA / NYXH Daily stock chart

NYXH.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 28.81 214.85B
IUI1.DE INTUITIVE SURGICAL INC 69.31 166.86B
BSX.DE BOSTON SCIENTIFIC CORP 39.18 133.56B
1BSX.MI BOSTON SCIENTIFIC CORP 39.52 133.38B
1MDT.MI MEDTRONIC PLC 17.48 113.17B
2M6.DE MEDTRONIC PLC 17.56 110.81B
1SHL.MI SIEMENS HEALTHINEERS AG 25.27 60.49B
BOX.DE BECTON DICKINSON AND CO 16.4 60.33B
SHL.DE SIEMENS HEALTHINEERS AG 23.49 59.08B
1EW.MI EDWARDS LIFESCIENCES CORP 26.07 39.21B
EWL.DE EDWARDS LIFESCIENCES CORP 26.65 37.76B
DC4.DE DEXCOM INC 48.5 28.81B

About NYXH.BR

Company Profile

NYXH logo image Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 147 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Company Info

NYXOAH SA

Rue Edouard Belin 12

Mont-Saint-Guibert BRABANT-WALLON BE

Employees: 147

Company Website: https://www.nyxoah.com/

Phone: 3226121755

NYXOAH SA / NYXH.BR FAQ

What is the stock price of NYXOAH SA today?

The current stock price of NYXH.BR is 9.24 EUR. The price decreased by -1.28% in the last trading session.


What is the ticker symbol for NYXOAH SA stock?

The exchange symbol of NYXOAH SA is NYXH and it is listed on the Euronext Brussels exchange.


On which exchange is NYXH.BR stock listed?

NYXH.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for NYXOAH SA stock?

14 analysts have analysed NYXH.BR and the average price target is 14.68 EUR. This implies a price increase of 58.83% is expected in the next year compared to the current price of 9.24. Check the NYXOAH SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NYXOAH SA worth?

NYXOAH SA (NYXH.BR) has a market capitalization of 345.85M EUR. This makes NYXH.BR a Small Cap stock.


How many employees does NYXOAH SA have?

NYXOAH SA (NYXH.BR) currently has 147 employees.


What are the support and resistance levels for NYXOAH SA (NYXH.BR) stock?

NYXOAH SA (NYXH.BR) has a support level at 9.23 and a resistance level at 10.41. Check the full technical report for a detailed analysis of NYXH.BR support and resistance levels.


Is NYXOAH SA (NYXH.BR) expected to grow?

The Revenue of NYXOAH SA (NYXH.BR) is expected to grow by 24.94% in the next year. Check the estimates tab for more information on the NYXH.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NYXOAH SA (NYXH.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NYXOAH SA (NYXH.BR) stock pay dividends?

NYXH.BR does not pay a dividend.


When does NYXOAH SA (NYXH.BR) report earnings?

NYXOAH SA (NYXH.BR) will report earnings on 2025-03-13, after the market close.


What is the Price/Earnings (PE) ratio of NYXOAH SA (NYXH.BR)?

NYXOAH SA (NYXH.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.72).


NYXH.BR Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to NYXH.BR. When comparing the yearly performance of all stocks, NYXH.BR is a bad performer in the overall market: 78.41% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NYXH.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NYXH.BR. The financial health of NYXH.BR is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NYXH.BR Financial Highlights

Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -1.72. The EPS decreased by -2.14% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -37.11%
ROE -50.6%
Debt/Equity 0.21
Chartmill High Growth Momentum
EPS Q2Q%-86.47%
Sales Q2Q%29.71%
EPS 1Y (TTM)-2.14%
Revenue 1Y (TTM)32.65%

NYXH.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to NYXH.BR. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of -9.57% and a revenue growth 24.94% for NYXH.BR


Ownership
Inst Owners32.66%
Ins Owners20.26%
Short Float %N/A
Short RatioN/A
Analysts
Analysts81.43
Price Target14.68 (58.87%)
EPS Next Y-9.57%
Revenue Next Year24.94%